Search Results - "Vergadoro, F"

Tumor antigen CA 125 as a marker of ovarian epithelial carcinoma by Zanaboni, F, Vergadoro, F, Presti, M, Gallotti, P, Lombardi, F, Bolis, G

“…Serum CA 125 was measured in 100 patients with ovarian epithelial carcinoma at diagnosis and in follow-up. Levels over 35 U/ml were found in 43 (75.4%) of 57…”
Get more information

The value of endometrial cytology in a high risk population by Buratti, E, Cefis, F, Masserini, M, Goisis, F, Vergadoro, F, Bolis, G

“…Between January 1982 and November 1983, 335 women at risk for endometrial carcinoma, with or without symptoms, were screened on an out-patient basis at the 3rd…”
Get more information

Methotrexate with citrovorum factor in low-risk gestational trophoblastic tumor by Bolis, G, Colombo, N, Epis, A, Mangili, G, Vassena, L, Vergadoro, F, Belloni, C

“…From January 1976 through December 1985, methotrexate (MTX) with citrovorum factor (CF) was administered as primary treatment to 57 patients with low-risk…”
Get more information

Thyroid function in gestational trophoblastic tumors by Vergadoro, F, Tabacchi, L, Barbacini, P, Vassena, L, Zanaboni, F, Bolis, G

“…Thyroid function was assessed in a total of 15 cases, 7 of whom had choriocarcinoma and 8 hydatidiform mole, by measuring free T3, free T4, thyroxin-binding…”
Get more information

The role of surgery in gestational trophoblastic disease by Bolis, G, Belloni, C, Vergadoro, F, Colombo, N, Buratti, E, Mangioni, C

“…Fifty-eight consecutive patients with malignant trophoblastic tumors of gestational origin were treated at the 1st Department of Obstetrics and Gynecology of…”
Get more information

EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT) by Bolis, G, Bonazzi, C, Landoni, F, Mangili, G, Vergadoro, F, Zanaboni, F, Mangioni, C

“…From June 1980 through December 1985, 36 high-risk GTT patients received Bagshawe's EMA/CO regimen, 22 as first-line, and 14 as second-line treatment, after…”
Get more information

Intraperitoneal chromic phosphate P 32 suspension therapy of malignant peritoneal cytology in endometrial carcinoma by Soper, J T, Creasman, W T, Clarke-Pearson, D L, Sullivan, D C, Vergadoro, F, Johnston, W W

“…Malignant peritoneal cytology in patients with endometrial carcinoma is a poor prognostic feature, identifying patients at high risk for early intra-abdominal…”
Get more information